Model
Edge
4D Molecular Therapeutics
0001877012
Filing type
4
Filing date
Mar 26, 2026
Updated
Mar 27, 2026 ยท 2:30 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership